| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.17 | 0.0001 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.15 | 0.0004 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.18 | 0.0005 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.097 | 0.03 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.079 | 0.08 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.071 | 0.1 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.05 | 0.3 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | 0.048 | 0.3 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.045 | 0.3 |